相似文献
1
Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study.
BMJ. 2005 Nov 19;331(7526):1183-5. doi: 10.1136/bmj.38663.459039.7C.
2
Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study.
Am J Obstet Gynecol. 2020 Feb;222(2):172.e1-172.e12. doi: 10.1016/j.ajog.2019.08.042. Epub 2019 Aug 29.
3
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
BMJ. 2009 Jul 28;339:b2569. doi: 10.1136/bmj.b2569.
4
Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study.
BMJ. 2007 Nov 24;335(7629):1077. doi: 10.1136/bmj.39363.471806.BE. Epub 2007 Oct 24.
5
Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study.
BMJ. 2012 Oct 31;345:e6855. doi: 10.1136/bmj.e6855.
6
Cancer incidence among Finnish women with surgical treatment for cervical intraepithelial neoplasia, 1987-2006.
Int J Cancer. 2011 Mar 1;128(5):1187-91. doi: 10.1002/ijc.25428.
7
Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.
BMJ. 2014 Jan 14;348:f7361. doi: 10.1136/bmj.f7361.
8
Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England.
Gynecol Oncol. 2003 Jul;90(1):131-6. doi: 10.1016/s0090-8258(03)00231-2.
9
Pregnancy incidence and outcome among patients with cervical intraepithelial neoplasia: a retrospective cohort study.
BJOG. 2012 Jan;119(2):227-35. doi: 10.1111/j.1471-0528.2011.03042.x. Epub 2011 Jul 27.
10
The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women.
Gynecol Oncol. 2020 Apr;157(1):195-201. doi: 10.1016/j.ygyno.2020.01.023. Epub 2020 Jan 20.
引用本文的文献
1
Analysis of the triage value of multigene methylation testing for CIN2 + in hrHPV-positive patients.
Infect Agent Cancer. 2025 Apr 7;20(1):22. doi: 10.1186/s13027-025-00652-4.
2
Optimizing the Follow-Up Interval After Successful Cold Knife Conization of CIN3: A 10-Year Retrospective Cohort Study.
Cancer Med. 2025 Apr;14(7):e70825. doi: 10.1002/cam4.70825.
3
Vaginal Intraepithelial Neoplasia (VaIN) after Hysterectomy Is Strongly Associated with Persistent HR-HPV Infection.
Cancers (Basel). 2024 Jul 12;16(14):2524. doi: 10.3390/cancers16142524.
4
Anal Cancer and Anal Intraepithelial Neoplasia Risk among Patients Treated for HPV-Related Gynecological Diseases-A Systematic Review.
J Clin Med. 2023 Jun 22;12(13):4216. doi: 10.3390/jcm12134216.
5
2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia.
Curr Oncol. 2023 Jun 13;30(6):5738-5768. doi: 10.3390/curroncol30060431.
6
The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions.
Int J Mol Sci. 2023 Mar 30;24(7):6479. doi: 10.3390/ijms24076479.
7
Computer-aided diagnosis of cervical dysplasia using colposcopic images.
Front Oncol. 2022 Aug 5;12:905623. doi: 10.3389/fonc.2022.905623. eCollection 2022.
8
Effect of Condom Use after CIN Treatment on Cervical HPV Biomarkers Positivity: Prolonged Follow Up Study.
Cancers (Basel). 2022 Jul 20;14(14):3530. doi: 10.3390/cancers14143530.
9
Cervical cancer mortality in Norway according to screening attendance and age.
Acta Obstet Gynecol Scand. 2022 Sep;101(9):952-959. doi: 10.1111/aogs.14402. Epub 2022 Jun 11.
10
New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors.
Cancers (Basel). 2022 Jan 13;14(2):389. doi: 10.3390/cancers14020389.
本文引用的文献
1
Interval cervical cancer following treatment for cervical intraepithelial neoplasia.
Int J Gynecol Cancer. 2000 May;10(3):198-202. doi: 10.1046/j.1525-1438.2000.010003198.x.
2
Surgery for cervical intraepithelial neoplasia.
Cochrane Database Syst Rev. 2000(2):CD001318. doi: 10.1002/14651858.CD001318.
3
The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
Acta Obstet Gynecol Scand. 2000 Mar;79(3):221-6.
4
Screening histories of incidence cases of cervical cancer and high grade SIL. A comparison.
Acta Cytol. 1997 Sep-Oct;41(5):1431-8. doi: 10.1159/000332855.
5
Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia.
Lancet. 1997 Apr 5;349(9057):978-80. doi: 10.1016/s0140-6736(96)08295-5.
6
Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.
Br J Cancer. 1996 Apr;73(8):1001-5. doi: 10.1038/bjc.1996.196.
7
Data quality and quality control of a population-based cancer registry. Experience in Finland.
Acta Oncol. 1994;33(4):365-9. doi: 10.3109/02841869409098430.
8
Effect of a mass screening program on the risk of cervical cancer.
Am J Epidemiol. 1976 May;103(5):512-7. doi: 10.1093/oxfordjournals.aje.a112253.
Zotero 插件